INTERNATIONAL PATENT: HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD., 杭州中美华东制药有限公司 FILES APPLICATION FOR "NASAL DELIVERY PHARMACEUTICAL COMPOSITION OF LONG-ACTING GLP-1/GIP DUAL AGONIST"

GENEVA, July 19 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, Gong Shu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/071780) for "NASAL DELIVERY PHARMACEUTICAL COMPOSITION OF LONG-ACTING GLP-1/GIP DUAL AGONIST" on Jan 10, 2025. With publication no. WO/2025/149041, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is...